Pterostilbene mitigates experimental pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition
BackgroundThe natural compound pterostilbene (PTE) has multiple cardiovascular protective effects. However, its effects on pulmonary arterial hypertension (PAH)-associated vascular remodeling remain to be elucidated. This study investigated the effects of PTE on monocrotaline (MCT)-induced PAH in ra...
Saved in:
Main Authors: | Jie Wang, Yu Zhang, Junjun Liu, Fan Jiang, Xiaopei Cui, Weida Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1621700/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-aging Efficacy of a 0.1 % Pterostilbene Skincare Emulsion: A 28-Day Clinical Trial
by: Zongxiao Cen, et al.
Published: (2025-06-01) -
Stability and efficacy of pterostilbene nanoliposomes in cosmetic applications: A comprehensive study
by: Jianxin Li, et al.
Published: (2024-12-01) -
INDUCTION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION IN MCF-7-SNAI1 CELLS LEADS TO REORGANIZATION OF ADHERENS JUNCTIONS AND ACQUISITION OF MIGRATORY ACTIVITY
by: I. Y. Zhitnyak, et al.
Published: (2018-09-01) -
Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO‐1 pathways
by: Chang Xu, et al.
Published: (2021-12-01) -
Comparing the effectiveness of pterostilbene and sitagliptin on modulating inflammatory levels and inducing autophagy to improve atherosclerosis outcome: A preclinical study in rabbits [version 4; peer review: 2 approved]
by: Wisam J Mohammed, et al.
Published: (2025-05-01)